Сardioprotective agents with biaromatic structure. Part 3. Sodium channel blockers

This review continues a series of reviews on the analysis of compounds with cardioprotective properties in a number of biaromatic structures, which include a range of sodium channel blockers. Among voltage-gated sodium channels, the Nav1.5 isoform is the most abundant in the heart. Sodium channel bl...

Full description

Saved in:
Bibliographic Details
Main Author: G. V. Mokrov
Format: Article
Language:Russian
Published: LLC “Publisher OKI” 2022-12-01
Series:Фармакокинетика и Фармакодинамика
Subjects:
Online Access:https://www.pharmacokinetica.ru/jour/article/view/326
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849345327814934528
author G. V. Mokrov
author_facet G. V. Mokrov
author_sort G. V. Mokrov
collection DOAJ
description This review continues a series of reviews on the analysis of compounds with cardioprotective properties in a number of biaromatic structures, which include a range of sodium channel blockers. Among voltage-gated sodium channels, the Nav1.5 isoform is the most abundant in the heart. Sodium channel blockers have historically been called "class I antiarrhythmics". Among the compounds of this type, a biaromatic structure mainly have the Nav1.5 late current blockers belonging to the Id subclass of antiarrhythmic drugs. Leader molecules from this subgroup, such as ranolazine, GS-458967, and F15845, reduce action potential recovery time and suppress trigger activity induced by early post-depolarization. They are effective for the treatment of stable angina and ventricular tachycardia.
format Article
id doaj-art-7d7b5b1d337342b49e6d0f3fbf3d161d
institution Kabale University
issn 2587-7836
2686-8830
language Russian
publishDate 2022-12-01
publisher LLC “Publisher OKI”
record_format Article
series Фармакокинетика и Фармакодинамика
spelling doaj-art-7d7b5b1d337342b49e6d0f3fbf3d161d2025-08-20T03:42:30ZrusLLC “Publisher OKI”Фармакокинетика и Фармакодинамика2587-78362686-88302022-12-01033910.37489/2587-7836-2022-3-3-9305Сardioprotective agents with biaromatic structure. Part 3. Sodium channel blockersG. V. Mokrov0FSBI «Zakusov Institute of Pharmacology»This review continues a series of reviews on the analysis of compounds with cardioprotective properties in a number of biaromatic structures, which include a range of sodium channel blockers. Among voltage-gated sodium channels, the Nav1.5 isoform is the most abundant in the heart. Sodium channel blockers have historically been called "class I antiarrhythmics". Among the compounds of this type, a biaromatic structure mainly have the Nav1.5 late current blockers belonging to the Id subclass of antiarrhythmic drugs. Leader molecules from this subgroup, such as ranolazine, GS-458967, and F15845, reduce action potential recovery time and suppress trigger activity induced by early post-depolarization. They are effective for the treatment of stable angina and ventricular tachycardia.https://www.pharmacokinetica.ru/jour/article/view/326аntiarrhythmicscardioprotectorsna-channels blockersbiaromatic compounds
spellingShingle G. V. Mokrov
Сardioprotective agents with biaromatic structure. Part 3. Sodium channel blockers
Фармакокинетика и Фармакодинамика
аntiarrhythmics
cardioprotectors
na-channels blockers
biaromatic compounds
title Сardioprotective agents with biaromatic structure. Part 3. Sodium channel blockers
title_full Сardioprotective agents with biaromatic structure. Part 3. Sodium channel blockers
title_fullStr Сardioprotective agents with biaromatic structure. Part 3. Sodium channel blockers
title_full_unstemmed Сardioprotective agents with biaromatic structure. Part 3. Sodium channel blockers
title_short Сardioprotective agents with biaromatic structure. Part 3. Sodium channel blockers
title_sort сardioprotective agents with biaromatic structure part 3 sodium channel blockers
topic аntiarrhythmics
cardioprotectors
na-channels blockers
biaromatic compounds
url https://www.pharmacokinetica.ru/jour/article/view/326
work_keys_str_mv AT gvmokrov sardioprotectiveagentswithbiaromaticstructurepart3sodiumchannelblockers